In the analysis of clinical sample, mutations in SETD2 led to the enrichment of tumor cell surface mutation-specific neoantigens, such as mutational load (TMB) microsatellite instability-high (dMMR/MSI-H). The gene discussed is SETD2; the disease is neoplasm.